Literature DB >> 20636827

Surrogate end-points in clinical practice: are we providing worse care?

J H Martin, M F Fay.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20636827     DOI： 10.1111/j.1445-5994.2010.02248.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


× No keyword cloud information.
  3 in total

1.  When less is more - efficacy with less toxicity at the ED50.

Authors:  Simon Dimmitt; Hans Stampfer; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2017-04-06       Impact factor: 4.335

2.  The impact of pre-intervention rate of kidney function change on the assessment of CKD progression.

Authors:  Robert G Fassett; Dominic P Geraghty; Jeff S Coombes
Journal:  J Nephrol       Date:  2014-02-07       Impact factor: 3.902

Review 3.  Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease.

Authors:  Sheila Seleri Assunção; Reisa A Sperling; Craig Ritchie; Diana R Kerwin; Paul S Aisen; Claire Lansdall; Alireza Atri; Jeffrey Cummings
Journal:  Alzheimers Res Ther       Date:  2022-04-19       Impact factor: 8.823
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.